Browse diseases

…Background Reducing hospitalisations in heart failure (HF) requires organisational models for rapid optimisation, edu…

…ociation between cerebral tissue oxygen saturation (SctO 2) and heart failure (HF) has been previously studied, but the prognostic significan…

…eceptor agonists (GLP-1 RAs) improve cardiovascular outcomes in type 2 diabetes (T2D), and SGLT2i reduces events in heart failure (HF). However…

…on on the accuracy of these tools.Methods A total of 116 stable HF patients with no symptoms indicative of systemic hypotension ha…

…Aim Hospitalisation for heart failure (HF) carries a high risk of readmission and adverse patient out…

…Introduction The UK National Heart Failure Audit (England and Wales) reports 43% of patients hospitalised …

…action. In FINEARTS-HF, 1 it reduced the composite of worsening heart failure and cardiovascular death, mainly through fewer hospitalisations…

…rescribed non-pharmacological intervention in the management of heart failure (HF). However, data on its efficacy and safety are scarce. Rece…

…Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between its severity a…

…iated with increased HF risk independent of major risk factors. Hypertension induced broad metabolic reprogramming across plasma and urine, …

…hether they are a useful treatment for venous congestion due to heart failure (HF).Methods A rapid systematic review was conducted following …

…etics are a cornerstone of therapy for people hospitalised with heart failure (HF). There are several strategies that might enhance diuresis …